ARK ISRAEL INNOVATIVE TECHNOLOGY ETF (IZRL) HOLDINGS As of 01/15/2021

Company Ticker CUSIP Shares Market Value($) Weight(%)

1 STRATASYS LTD SSYS M85548101 161,535 5,144,889.75 4.17 2 CERAGON NETWORKS LTD CRNT M22013102 970,011 4,704,553.35 3.82 3 GAMIDA CELL LTD GMDA M47364100 477,715 4,485,743.85 3.64 4 PERION NETWORK LTD PERI M78673114 325,063 4,222,568.37 3.43 5 FATTAL HOLDINGS 1998 LTD FTAL BG1YKN5 37,491 4,206,111.27 3.41 6 FIVERR INTERNATIONAL LTD FVRR M4R82T106 15,106 4,035,265.78 3.27 7 ONE SOFTWARE TECHNOLOGIES LT ONE 6987709 30,737 3,985,925.21 3.23 8 RADA ELECTRONIC INDS LTD RADA M81863124 373,569 3,761,839.83 3.05 9 LTD GILT M51474118 503,303 3,684,177.96 2.99 10 LTD TSEM M87915274 125,577 3,572,665.65 2.90 11 INMODE LTD INMD M5425M103 61,403 3,549,707.43 2.88 12 CYBERARK SOFTWARE LTD/ISRAEL CYBR M2682V108 22,168 3,546,880.00 2.88 13 NOVA MEASURING INSTRUMENTS NVMI M7516K103 43,063 3,365,804.08 2.73 14 CAMTEK LTD CAMT M20791105 135,784 3,313,129.60 2.69 15 ALLOT LTD ALLT M0854Q105 244,132 3,307,988.60 2.68 16 ITURAN LOCATION AND CONTROL ITRN M6158M104 175,544 3,298,471.76 2.68 17 CELLCOM ISRAEL LTD CEL B23WQK8 630,559 3,277,361.79 2.66 18 TARO PHARMACEUTICAL INDUS TARO M8737E108 41,621 3,233,535.49 2.62 19 PARTNER COMMUNICATIONS CO PTNR 6374420 625,070 3,187,569.83 2.59 20 TEVA PHARMACEUTICAL-SP ADR TEVA 881624209 266,909 3,192,231.64 2.59 21 DANEL (ADIR YEOSHUA) LTD DANE 6253433 20,251 3,088,199.97 2.51 22 SILICOM LTD SILC M84116108 69,487 3,082,443.32 2.50 23 NICE LTD - SPON ADR NICE 653656108 10,484 2,869,470.80 2.33 24 RADWARE LTD RDWR M81873107 101,170 2,815,055.25 2.28 25 ELBIT SYSTEMS LTD ESLT 6308913 20,807 2,780,426.98 2.26 26 HILAN LTD HLAN 6267230 56,856 2,676,498.38 2.17 27 SAPIENS INTERNATIONAL CORP SPNS G7T16G103 81,084 2,514,820.26 2.04 28 SOFTWARE TECH CHKP M22465104 19,443 2,481,121.23 2.01 29 MATRIX IT LTD MTRX 6747754 103,119 2,322,941.03 1.88 30 AYALA PHARMACEUTICALS INC AYLA 05465V108 175,832 2,275,266.08 1.85 31 AUDIOCODES LTD AUDC M15342104 74,324 2,283,233.28 1.85 32 BATM ADVANCED COMMUNICATIONS BATM B85PTW0 1,646,348 2,196,475.31 1.78 33 UROGEN PHARMA LTD URGN UQ M96088105 109,426 2,191,802.78 1.78 34 BEZEQ THE ISRAELI TELECOM CO BEZQ 6098032 2,044,679 2,197,481.96 1.78 35 KAMADA LTD KMDA B0L2CR5 310,890 2,133,857.55 1.73 36 POLYPID LTD PYPD M8001Q118 203,435 2,115,724.00 1.72 37 WIX.COM LTD WIX M98068105 8,698 2,098,653.44 1.70 38 COMPUGEN LTD CGEN M25722105 149,987 1,951,330.87 1.58 39 INC PSTI 72940R300 239,254 1,923,602.16 1.56 40 REDHILL BIOPHARMA LTD-SP ADR RDHL 757468103 247,756 1,840,827.08 1.49 41 BIONDVAX PHARMACEUTICALS-ADR BVXV 09073Q105 61,866 231,997.50 0.19 42 MORGAN STANLEY GOVT INSTL 8035 X9USDMORS 122,232 122,231.51 0.10

The principal risks of investing in ARK ETFs include equity, market, management and non-diversification risks, as well as fluctuations in market value and net asset value ("NAV"). Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ETF before investing. This and other information are contained in each ETF's prospectus, which may be obtained by contacting the ETF's transfer agent The Bank of New York Mellon or by clicking here. Please read the prospectus carefully before you invest. The market price of ETF shares may differ significantly from their NAV during periods of market volatility. ETF shares may only be redeemed directly with the ETF at NAV by Authorized Participants, in very large creation units. Holdings are subject to change without notice and are not a recommendation to buy or sell any security. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns. ©2021, ARK Investment Management LLC. All content is original and has been researched and produced by ARK Investment Management LLC unless otherwise stated. No part of this content may be reproduced in any form, or referred to in any other publication, without the express written permission of ARK Investment Management LLC. All statements made regarding companies, securities or other financial information on this site or any sites or articles relating to ARK Investment Management LLC are strictly beliefs and points of view held by ARK Investment Management and are subject to change without notice. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product.